Description
A modulator of acetylcholine release; dose-dependently (50, 75, and 100 µg/kg, i.v.) decreases plasma glucose levels and increases insulin-like immunoreactivity and C-peptide in rats; increases β-endorphin; increases autophagy through AMPKα activation preventing cardiac hypertrophy progression
Formal name: 4-[(1E)-3-hydroxy-1-propen-1-yl]-2,6-dimethoxyphenyl-β-D-glucopyranoside
Synonyms: Eleutheroside B|NSC 287441
Molecular weight: 372.4
CAS: 118-34-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|CaMKs||Product Type|Biochemicals|Natural Products|Glycosides||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cardiovascular System|Heart|Myocardial Hypertrophy||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Immunology & Inflammation